PlainRecalls
FDA Devices Moderate Class II Terminated

ProterixBio SARS-CoV-2 (RBD) IgG Antibody Test, and associated ProterixBio Dried Blood Spot Collection Kit, no model number

Reported: May 18, 2022 Initiated: April 17, 2022 #Z-1058-2022

Product Description

ProterixBio SARS-CoV-2 (RBD) IgG Antibody Test, and associated ProterixBio Dried Blood Spot Collection Kit, no model number

Reason for Recall

FDA review concluded that the test is insufficiently supported by clinical performance data, and results reported may not have been accurate (false positives or false negatives).

Details

Recalling Firm
PROTERIXBIO
Units Affected
640 kits
Distribution
Domestic distribution to CA CO FL IA MA MO NH NY OH OK TX VA
Location
Billerica, MA

Frequently Asked Questions

What product was recalled?
ProterixBio SARS-CoV-2 (RBD) IgG Antibody Test, and associated ProterixBio Dried Blood Spot Collection Kit, no model number. Recalled by PROTERIXBIO. Units affected: 640 kits.
Why was this product recalled?
FDA review concluded that the test is insufficiently supported by clinical performance data, and results reported may not have been accurate (false positives or false negatives).
Which agency issued this recall?
This recall was issued by the FDA Devices on May 18, 2022. Severity: Moderate. Recall number: Z-1058-2022.